The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $661,744
- $4,917,109 in all
- Institutions
- 7
- 7 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
7
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- LOYOLA UNIVERSITY CHICAGO1
- OHIO STATE UNIVERSITY1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-G (J1))7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Non-coding RNAs in resilience to Alzheimer’s Disease1R01AG082093-01 | Hide, Winston AlexanderKim, Doo YeonSlack, Frank J. | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $862,503 | Study section ZAG1 |
| FY2023 | Enhancer RNAs in brain gene regulation and Alzheimer's disease1R01AG082132-01 | Li, Wenbo | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | First-year cost $783,820 | Study section ZAG1 |
| FY2023 | Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology1R01AG082113-01 | Amer, Amal O | OHIO STATE UNIVERSITY, OH | First-year cost $674,566 | Study section ZAG1 |
| FY2023 | Sex-specific regulation of microRNAs in Alzheimer Disease1R01AG082135-01 | Pak, Toni R. | LOYOLA UNIVERSITY CHICAGO, IL | First-year cost $661,744 | Study section ZAG1 |
| FY2023 | The role of IncRNA Neat1 in Alzheimer's disease and related memory deficits1R01AG082089-01 | Lubin, Farah Dominique | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $657,110 | Study section ZAG1 |
| FY2023 | MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer’s disease1R01AG082142-01 | Wang, Wang-Xia | UNIVERSITY OF KENTUCKY, KY | First-year cost $654,613 | Study section ZAG1 |
| FY2023 | miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention1R01AG082140-01 | Deshmukh, Mohanish P | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $622,753 | Study section ZAG1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.